← Leaderboards
Peng Zhang
Alph Technologies, Llc
$241,018
Attributed
$241,018
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$241,018 · 1
By mechanism
R41$241,018 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Antibiotic Resistance”
- Urs Ochsner · Crestone, Inc.$36,950,837
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$25,064,821
- Bruce Blough · Research Triangle Institute$19,880,022
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Terry Roemer · Prokaryotics, Inc.$13,917,276
Research focus
Antibiotic ResistanceAntibioticsAntibiotic TherapyAntimicrobialAntimicrobial ResistanceAqueousAttentionBacteriaBacterial InfectionsBaseBiologicalBiomaterial CompatibilityCell DeathCellsClinical ApplicationClinical PracticeClinical TrialsCollaborationsCytotoxicityDrug DevelopmentDrug DiscoveryDrug ResistanceDrug Resistant PathogenAnimal Testing